“What is a fatty liver?” Dr Lange conscientiously draws our attention to the differences in fatty liver disease and the current findings of research. She prudently enlightens us about the causes, significance, diagnosis and treatment methods. The increasing incidence of MAFLD/NAFLD, approx. 25% of the population in Switzerland is affected, should make us all prick up our ears!

More information: https://www.swisshepa.org/en/liver-diseases/metabolic-dysfunction-associated-fatty-liver-disease-mafld-previously-known-as-nafld-nash/